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Abstract 45	  
Background -There have been anecdotal reports of episodic involuntary movements in the 46	  
Border terrier dog breed for over a decade. Recently, it has been hypothesized that this condition 47	  
may be a form of paroxysmal dystonic choreoathetosis. The aim of this study was to characterize 48	  
the phenomenology and clinical course of this condition and compare it to known human 49	  
movement disorders.  50	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Methods - Data were collected retrospectively from clinical cases treated by veterinary 51	  
neurologists and additional information was collected prospectively with an ad hoc online survey 52	  
directed to owners of affected dogs. 53	  
Results -	  The episodes are characterized by generalized dystonia, tremors, titubation and  in some 54	  
cases, autonomic signs such as salivation and vomiting. The median age at onset of the episodes 55	  
was 3 years and the interval between clusters of episodes could last several months. Most of the 56	  
episodes occurred from rest and 67% of the owners reported that the episodes were associated 57	  
with a trigger, most often excitement. Some owners reported an improvement after changing their 58	  
dog’s diet. We hypothesize that the Border terrier attacks represent a form of paroxysmal non-59	  
kinesigenic dyskinesia (PNKD).  60	  
Conclusions -	  The finding of a dystonia phenotype within an inbred population suggests a genetic 61	  
predisposition and elucidating the genetic cause could facilitate improved understanding of 62	  
dystonia. This genetic predisposition and the effect of treatment with anticonvulsant drugs and 63	  
dietary changes on the severity of the paroxysms warrant further investigation on this condition. 64	  
 65	  
Introduction 66	  
There have been anecdotal reports of episodic involuntary movements in the Border terrier dog 67	  
breed for over a decade.1, 2 A first attempt to characterise the clinical phenotype was only 68	  
published recently.3 The authors reported on the phenotypic characterization of 29 pure bred 69	  
Border Terriers with Canine Epileptoid Cramping Syndrome and hypothesized that this condition 70	  
may be a form of paroxysmal dystonic choreoathetosis. The study was based on a survey of 71	  
owners of affected dogs and 50% of the owners reported an improvement in the frequency of the 72	  
episodes after changing the dog’s diet. The episodes in the Border terrier are characterized by 73	  
whole body tremors with unimpaired consciousness. The aim of this study was to further 74	  
characterize the phenomenology and clinical course of this condition collecting data from both 75	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veterinary neurologists and owners of affected dogs and compare this condition to known human 76	  
movement disorders.  77	  
 78	  
Materials and methods  79	  
This study was approved by the ethical and animal care committee of the Royal Veterinary 80	  
College, University of London, England (approval number URN 2011 1135). Owners of Border 81	  
terriers with episodes of tremors or muscle spasms were invited to participate in an ad hoc online 82	  
survey. The survey ran for four months, from April to July 2012. The questionnaire was designed 83	  
by three board-certified veterinary neurologists and included 83 questions, including open and 84	  
closed-ended questions. The inclusion criteria were breed (only dogs identified by the responder 85	  
as Border terriers were included) and history of more than one episode of involuntary movements 86	  
with apparent preservation of consciousness. Dogs described to have generalized tonic-clonic 87	  
seizures were excluded from the study unless these were in addition to a different type of 88	  
episodes characterized by paroxysmal involuntary movements with preservation of consciousness. 89	  
The decision to include dogs with a history of generalized seizures was based on the fact that the 90	  
co-occurrence of epilepsy and paroxysmal dyskinesias and ataxias is reported in humans and may 91	  
be present also in veterinary patients.4 Dogs older than 6 years at the onset of the clinical signs 92	  
were excluded by the study if information on brain MRI and cerebrospinal fluid (CSF) analysis 93	  
was not available, as they would be more likely to have a structural etiology for the episodes.5 It 94	  
was decided that each responder could enter only one affected dog and the information collected 95	  
with the questionnaire was compared with information on clinical cases collected retrospectively.  96	  
Description of the episodes provided in the survey and, when available video recordings, were 97	  
reviewed to characterize the nature of the episodes. Some owners were contacted by e-mail for 98	  
data verification. Questionnaires that included a detailed description of the episode and answers 99	  
to a minimum of 50% of the 83 questions were included in the study. 100	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Clinical cases were identified searching the medical records of the authors’ practices from 2006 101	  
to July 2012 for Border terriers presenting with episodes of involuntary movements without loss 102	  
of consciousness, and with a minimal work up including hematology and biochemical panel. 103	  
Information on signalment, history and clinical presentation were derived retrospectively from the 104	  
records of the clinical cases.  105	  
Data obtained from web-based survey was compared to data derived from the records of clinical 106	  
cases and differences were considered significant at P≤0.05 [analyses conducted with R version 107	  
3.0.1, The R Foundation for Statistical Computing (2013)].  The effect of the independent 108	  
variable (group: prospective online questionnaire or retrospective clinical cases) on continuous 109	  
dependent variables was analyzed by a generalized linear model (GLM) if the dependent variable 110	  
was normally distributed and variances homogeneous, and by Kruskal-Wallis one-way analysis of 111	  
variance if data violated assumptions of normality and homogeneity.  Binomial dependent 112	  
variables (i.e., response either “yes” or “no”) were modeled according to the independent variable 113	  
by GLM with a binomial link function.  114	  
 115	  
Results 116	  
Study population 117	  
There were 99 responders to the survey; 62 questionnaires did not meet the inclusion criteria 118	  
including a detailed description of the episodes and answers to a minimum of 50% of the 119	  
questions and were therefore excluded from analysis. Eighteen clinical cases were identified in 120	  
the medical records of four UK veterinary referral hospitals. However, two dogs (one in the 121	  
survey and one in the clinical group) were subsequently excluded from the study due to a late 122	  
onset of clinical signs and a lack of information on brain MRI and CSF analysis. In total, 123	  
information on 53 affected Border terriers (36 questionnaires and 17 clinical cases) was analyzed 124	  
in this study. Forty-four dogs were in United Kingdom, 3 in United States of America and one 125	  
each in Canada, Australia, Germany and Sweden. Seven owners reported knowledge of similar 126	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episodes in dogs related to theirs. There were 28 male and 23 female dogs, of these 10 were 127	  
sexually intact dogs and 40 were neutered, information on the gender of 2 dogs and on the 128	  
reproductive state of a female dog was not available. The dogs were aged between 10 months and 129	  
14 years (median, 6 years) at the time of the survey.   130	  
Results of statistical analysis 131	  
There was no significant difference between the survey group and the clinical cases group for any 132	  
of the continuous variables, such as age of onset of clinical signs, frequency of the episodes, 133	  
highest number of episodes per day, median duration of the episodes and recovery time, and 134	  
duration-dose of treatment. Also, no significant difference was detected for any of the binomial 135	  
dependent variables such as bilateral clinical signs, presence of increased muscle tone, ability to 136	  
stand and presence of autonomic signs. Since no significant differences were detected between 137	  
the survey group and the clinical cases group for any of the continuous or binomial dependent 138	  
variables, we report the data below as one group. 139	  
Age of onset 140	  
The age of onset of the attacks was 3.1 +/- 0.3 years (mean +/- SE, median 3 years, N=51 dogs, 141	  
range 0.3 to 6.5 years). 142	  
Occurrence of events 143	  
Most of the episodes occurred from rest (87% or 34/39 dogs), with less from sleep (50% or 19/38 144	  
dogs) or during exercise (42% or 18/43 dogs). In 75% (30/40) of the dogs the episodes occurred 145	  
at any time during the day, the remaining dogs tended to have episodes in the evenings (nine 146	  
dogs) or during the night (five dogs). Most of the owners (67% or 29/43 dogs) reported that the 147	  
episodes were associated with a trigger (excitement, n=10; stress, n=9; food, n=7; extreme 148	  
temperatures, n=6; loud sudden noise, n=5; visual stimuli and startle, n=3 dogs each).  149	  
Characterization of the episodes 150	  
The videos illustrate the typical presentation of the episodes based on the authors’ experience. 151	  
The episode in video 1 appeared to be triggered by excitement, developing seconds after the dog 152	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was separated from the owner and admitted to the hospital. Generalized body tremors were 153	  
evident throughout the episode and were associated with an involuntary lateral body sway similar 154	  
to titubation. The dog’s gait became progressively stiff and hypometric until the dog comes to a 155	  
stop with a wide based stance and showed generalized tremors. The dog was examined by one of 156	  
the authors (KMH) during this paroxysm of generalized dystonia, he appeared to be conscious 157	  
and was found to have normal menace response in both eyes and conscious postural reactions in 158	  
all four limbs, no autonomic signs were detected. Diazepam 1 mg/kg per rectum, followed by 0.5 159	  
mg/kg intravenously did not appear to have an effect; the clinical signs subsided gradually over 160	  
the course of approximately 5 minutes. 161	  
The second video (Video 2) is an excerpt of a slightly different type of episode. The complete 162	  
video showed the dog in sternal recumbency turning his head side-to-side, manifesting 163	  
progressive stiffening of the muscles of limbs, trunk, and neck. Then, the dog developed 164	  
titubation and tremors and dystonia affecting limbs, tail and trunk.  An episode of vomiting was 165	  
followed by panting and salivation. When the dog attempted to walk the limb movements were 166	  
initiated but not controlled appropriately and there was poor coordination between joint flexor 167	  
and extensor muscles,  168	  
Owners reported muscle tremors in 85% (40/47) of the dogs, 57% (27/47) of the owners indicated 169	  
that the tremors affected the trunk and 49% (23/47) limbs, see Table 1 for more details on the 170	  
clinical presentation, information derived from survey and clinical cases groups was pooled. 171	  
During the episodes both sides of the body were similarly affected in 85% (39/46) of the dogs. 172	  
The owners described increased muscle tone during the episodes in 82% (37/45) of the dogs. 173	  
Sixty-four per cent (27/42) of the dogs could not stand during an episode, 43/45 (95%) owners 174	  
reported their pet was able to look at them in the eyes during an episode and had no apparent 175	  
impairment in consciousness, the owners of the remaining 10 dogs (2 negative and 8 blank 176	  
answers) were contacted and provided a statement or video suggesting no impairment in their 177	  
dogs’ consciousness during an episode (e.g. attempting to eat during an episode). Fifty-six 178	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percent (26/46) of the owners described autonomic signs such as salivation, urination, defecation 179	  
or vomiting associated with the episodes, more frequently salivation (22/46) and vomiting (11/46) 180	  
in 48% and 24% of dogs respectively. Twenty-nine owners reported that their dogs experienced 181	  
always the same type of episode and 18/47 dogs (38%) had different types of episodes. In 13 dogs, 182	  
the episodes differed from each other in severity or duration; the owners of five dogs also 183	  
described sporadic generalized tonic-clonic seizures with loss of consciousness. In two dogs, one 184	  
single generalized seizure was observed one and two years prior of the onset of the attacks 185	  
described here. Information on frequency and duration of the episodes and recovery time is 186	  
reported in Table 2. 187	  
Diagnostic work up and co morbidity 188	  
Blood work (haematology, biochemistry and bile acid stimulation test) performed in 55% (15/27) 189	  
of the dogs did not reveal any significant clinical abnormality. One dog had an inter-ictal 190	  
electroencephalogram (EEG) performed and another dog had electromyography performed while 191	  
under general anaesthesia, both diagnostic procedures had normal results. Head MRI was 192	  
performed in 15 dogs (13 dogs in the clinical cases group and 2 dogs from the survey group for 193	  
whom normal brain MRI results were reported by owners) and did not revealed any significant 194	  
abnormality. 195	  
The cerebrospinal fluid analysis was slightly abnormal in 2/11 dogs, one sample of cerebrospinal 196	  
fluid was defined as mildly reactive based on the presence of reactive lymphocytes and activated 197	  
macrophages on cytology; cell count and protein content were normal. Another cerebrospinal 198	  
fluid analysis showed a total nucleated cell count of 11 cells/µL (normal < 5 cells/µL), mixed 199	  
pleocytosis and normal protein content. The neurological examination in both dogs was normal; 200	  
long-term follow up was not available. 201	  
Twenty-eight percent (7/25) of the dogs had concurrent dermatological conditions, 7 dogs had 202	  
otitis externa and 5 of these dogs had also suspected allergic dermatitis; gastrointestinal problems 203	  
affected 16% (4/25) of the dogs. 204	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Clinical course and treatment 205	  
The frequency of the episodes was variable, from one per day to one per year; 6 owners reported 206	  
a progressive increase in frequency and 2 owners reported clusters of episodes within a week with 207	  
intervening normal periods of several months. Thirty-five per cent (18/51) of the dogs received 208	  
medication for this condition, and 17 of these dogs were receiving anticonvulsant medications, 209	  
one dog received clomipramine. One dog treated with potassium bromide and 8/10 (80%) dogs 210	  
treated with phenobarbital showed an improvement in the frequency of the episodes. Three dogs 211	  
receiving phenobarbital had not experienced an episode in one (n=1) or two years (n=2), 3 other 212	  
dogs had a significant (>50%) decrease in the frequency of the episodes, none of these dogs had a 213	  
concurrent history of seizures. 214	  
Five owners (5/41 or 12%) reported an improvement after switching to a different commercial 215	  
diet (n=4) or elimination of a specific type of treats (i.e. rawhide chews, n=1), two dogs were 216	  
reported to be free of episodes for one and eight years, and two owners reported a significant 217	  
(>50%) decrease in the frequency of the episodes. 218	  
 219	  
Discussion 220	  
The objective of this study was to describe the phenomenology of paroxysmal involuntary 221	  
movements in Border terriers to advance our knowledge of this condition and generate 222	  
hypotheses for future pathophysiology and genetic studies.  223	  
The limitations of this study were its retrospective nature and the use of information derived from 224	  
a questionnaire for 36/53 dogs (68%). Information from clinical cases was compared by means of 225	  
statistical analysis with information derived by the questionnaire and pooled together after finding 226	  
no significant differences for binomial or continuous variables.  The objective was to achieve a 227	  
better characterization of this rare condition of Border terrier dogs that presents with recurrent 228	  
episodes of involuntary movements of brief and variable duration similar to paroxysmal 229	  
dyskinesias described in humans.6 230	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Border terriers of either gender in Europe, North America and Australia develop attacks of 231	  
involuntary movements at the median age of 3 years. Their frequency is variable from multiple 232	  
attacks per day to 1 per year; the median duration of the attacks is 5 minutes, but in 30% of the 233	  
dogs the attacks lasted between 15 minutes to 2 hours. During the episodes the dogs appear to be 234	  
disoriented, but responsive to stimuli, with dystonia, tremors affecting neck, trunk and limbs, and 235	  
titubation (Video 1). Affected dogs are normal in between episodes based on the results of the 236	  
neurological examination in 17/53 dogs (32%) and owners’ evaluation in 36/53 dogs (68%). The 237	  
clinical presentation of the described Border terrier attacks is similar to primary or familial forms 238	  
of paroxysmal dyskinesias in humans.6  239	  
The phenotypic classification of paroxysmal dyskinesias in humans is based on precipitating 240	  
factors and, at this time, includes three types of paroxysmal dyskinesias:  paroxysmal kinesigenic 241	  
(PKD), non-kinesigenic (PNKD), and exercise induced (PED).7 Paroxysmal kinesigenic 242	  
dyskinesias (PKDs) are triggered by sudden movements and the attacks are typically brief, lasting 243	  
only seconds. Attacks of paroxysmal non-kinesigenic dyskinesia (PNKD) have a longer duration 244	  
compared with PKD and are not induced by sudden movement but can be triggered by alcohol, 245	  
coffee, or strong emotions. Finally, attacks of paroxysmal exercise-induced dyskinesia (PED) are 246	  
triggered by physical exhaustion after continuous exertion.7 Most of the attacks in Border terriers 247	  
occurred from rest (87% or 34/39 dogs), but some owners (67% or 29/43 dogs) reported that the 248	  
attacks could be associated with a trigger, in particular excitement, stress and food.  We 249	  
hypothesize that, since a kinesigenic trigger was not identifiable, the Border terrier attacks 250	  
represent a form of paroxysmal non-kinesigenic dyskinesia (PNKD). Similar to the Border terrier 251	  
attacks, PNKD attacks in humans tend to occur only few times per year (up to several times per 252	  
week) and last longer than in PKD (from 10 minutes up to 12 hours, although usually not longer 253	  
than 1 hour).6 Eighty percent of genetically proven cases of human PNKD were found to have a 254	  
combination of dystonia and chorea; however 12% had only dystonia as seen in Video 1 and 2 of 255	  
Border terriers attacks. 6 Primary PNKD usually has no other associated interictal signs similar to 256	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the Border terriers in this study that had episodes of involuntary movements for a median time of 257	  
27 months without developing neurological signs between episodes.  PNKD attacks in humans 258	  
begin with premonitory symptoms, such as a sensation of tightness in 1 limb, involuntary 259	  
movements of the mouth, or anxiety; when the involuntary movements ensue, they often affect 260	  
only one side of the body and tend to spread or even generalize, similar observations of anxiety 261	  
and stiffening of one limb preceding the attacks and generalization of the attacks were also made 262	  
by owners of affected Border terriers as reported in Table 1.6 263	  
Finally, PNKD attacks in humans occur spontaneously at rest but more often after provocation by 264	  
alcohol or coffee.7 Interestingly, some of the findings in our study seem to suggest an association 265	  
between severity of the Border terrier attacks and diet: five owners reported an improvement in 266	  
the frequency of the episodes after switching to a different commercial diet and, for one dog, after 267	  
discontinuing rawhide chews. Similar findings were reported by Black and colleagues, in a recent 268	  
study describing this condition in 29 Border terriers; the study was based on an owner survey and 269	  
the authors reported that excitement, stress and waking from sleep could trigger the episodes in 270	  
some dogs, however, in the majority of the dogs the episodes appeared to occur at random.3 In 271	  
Black’s study, 26/29 (90%) owners changed their dog’s diet suspecting an association between 272	  
the attacks and diet.3 The majority of the owners selected hypoallergenic diets and over 50% of 273	  
the owners that participated in the survey reported a reduction in the frequency of the episodes.3 274	  
The limited number of dogs in our study and the fact that the new diets were all different does not 275	  
allow conclusions to be drawn. It is possible that the response to a change in diet might be a 276	  
placebo effect, as previously described in canine epilepsy trials, and induced by similar anecdotal 277	  
claims reported on the World Wide Web.8 It is also possible that the new diets improved the 278	  
Border terriers’ general health status and reduced their stress, in fact 28% of the dogs in this study 279	  
presented recurrent skin and ear problems and 16% of the dogs had recurrent gastrointestinal 280	  
problems, which may be associated with an underlying food hypersensitivity. However, there is 281	  
mounting evidence of an influence of the brain-gut-microbiome axis on central nervous system 282	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neurotransmission and enteric glial cells have been involved in the pathophysiology of 283	  
gastrointestinal disease such inflammatory bowel disease, gluten ataxia, but also Parkinson 284	  
disease.9-11 An association between diet and severity of Border terriers attacks as suggested by our 285	  
findings and Black’s study needs to be verified with a prospective study, however, if this 286	  
hypothesis was to be confirmed, the Border terrier dogs could represent an ideal spontaneous 287	  
model to investigate the effects of diet on paroxysmal dyskinesias.  288	  
The Border terriers included in Black’s study presented with episodes of abnormal involuntary 289	  
hyperkinetic movements or muscle tone; dogs with concurrent urination, defecation, 290	  
hypersalivation were excluded from the study.3 In our study, we found that 56% of the dogs with 291	  
similar episodes of involuntary movements showed autonomic signs during the episodes, most 292	  
commonly hypersalivation and vomiting reported in 48% and 24% of the dogs respectively. The 293	  
presence of autonomic signs could indicate that the episodes are part of a syndrome affecting 294	  
multiple areas of the nervous systems as in the case of some channelopathies described in 295	  
humans.12 296	  
The owners of five Border terriers in this study reported that their dogs also had generalized 297	  
tonic-clonic seizures with loss of consciousness, clonic movements and autonomic signs; four of 298	  
the dogs were clinical cases examined by veterinary neurologists, the owner of the last dog 299	  
(shown in Video 2) was contacted by e-mail and reported a progression toward more severe 300	  
episodes and suspected generalized seizures, however, video recordings of the suspected seizures 301	  
were not available for review. Further studies on this subset of Border terriers affected by 302	  
paroxysmal dyskinesia and possibly generalized seizures are necessary to elucidate the relation 303	  
between them and their significance in terms of treatment and prognosis. This association may be 304	  
coincidental since epilepsy is commonly diagnosed in UK Border terriers, in fact a recent study 305	  
found that in United Kingdom Border terriers are 2.7 times more likely to present epilepsy than 306	  
crossbred dogs.13 However, an association between paroxysmal dyskinesia and other neurological 307	  
disorders, like epilepsy and ataxia, has also been observed in individual human patients or 308	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families.4 Recently, a mutation in the KCNMA1 gene, encoding the pore-forming a subunit of the 309	  
large conductance calcium-sensitive potassium (BK) channel, has been discovered in a large 310	  
human family with coexistent generalized epilepsy and paroxysmal dyskinesia.14 Sixteen affected 311	  
individuals presented epileptic seizures (n = 4), paroxysmal nonkinesigenic dyskinesia (n = 7) or 312	  
both (n = 5).14  313	  
In this study we described the phenomenology of paroxysms of involuntary movements with 314	  
preservation of consciousness reported in Border terriers and found clinical similarities between 315	  
this condition and paroxysmal non-kinesigenic dyskinesia described in humans. The finding of a 316	  
dystonia phenotype within an inbred population suggests a genetic predisposition. Purebred dogs 317	  
represent an invaluable tool for mapping and cloning genes affecting human health.15, 16 The 318	  
unique history of the dog population characterized by founder effect and periodic population 319	  
bottlenecks along with stringent breeding programs led to a closed genetic pool within each breed. 320	  
17, 18 This reduced genetic variation compared with humans simplifies the mapping of simple and 321	  
complex diseases’ genes. Investigation of the genetic cause of the Border terrier phenotype could 322	  
improve understanding and treatment of the human condition. 323	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Table 1. Description of the attacks and clinical signs preceding and following them.   413	  
 Question type and response rate  Clinical presentation Number of 
dogs  
Clinical 
signs 
preceding 
the 
episodes  
Clinical signs (CEQ, RR = 58% or 31/53 
dogs) 
Normal 13 
Disorientated 11 
Ataxic 11 
Fearful 8 
Anxious  7 
Staring  6 
Pacing 5 
Crying 3 
Lethargic 2  
Additional clinical signs reported by the 
owners (OEQ, RR = 96% or 51/53 dogs) 
Stiffening of one limb  2 
Loud intestinal sounds, hypermetric gait 1 dog each 
Autonomic signs (CEQ, RR = 87% or 
46/53 dogs) 
Salivation 4 
Vomiting 1 
Signs 
during the 
episode 
Clinical signs (OEQ, RR = 96% or 51/53 
dogs) 
Tremors 30 
Loss of limb control 19 
Ataxia 18 
Muscle contractions 17  
Panting 15 
Hypermetric gait, arched back 4 each 
Head nodding, licking lips, head held down, 
swaying of the body side to side (titubation) 
3 dog each 
Loud intestinal noise, yawing, scooting 
backwards, distressed, watering eyes 
2 dog each 
Pawing at head, head turn 1 dog each 
Muscle tone (CEQ, RR = 85% or 45/53) Increased muscle tone 37 
Normal 4 
Decreased muscle tone 4 
Side of the body affected (CEQ, RR = 
87% or 46/53) 
Both sides affected 39 
Left side  4 
Right side 3 
Tremor localization (CEQ, RR = 89% or 
47/53) 
Trunk 27 
Limbs 23  
Face 3 
All of the above 8 
None of the above 7 
Autonomic signs (CEQ, RR = 87% or 
46/53 dogs) 
Salivation 17 
Vomiting 5 
Urination 3 
Defecation 1 
Clinical 
signs 
following 
the 
episodes 
Clinical signs (CEQ, RR = 64% or 34/53 
dogs) 
Normal 12 
Lethargic 14 
Ataxic 12 
Fearful 8 
Disorientated 7 
Staring  3 
Pacing, anxious, crying 1 dog each 
Autonomic signs (CEQ, RR = 87% or 
46/53 dogs) 
Salivation 1 
Vomiting 5 
Urination 3 
Defecation 1 
CEQ – close-ended question, OEQ – open-ended question, RR – response rate.   414	  
 415	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Table 2. Frequency and duration of the episodes and recovery time in Border Terriers with 416	  
paroxysms of involuntary movements. 417	   Parameters	   Results	  Frequency	  of	  the	  episodes	  (RR	  =	  53%	  or	  28/53)	   1	  per	  day	  to	  1	  per	  year	  (median	  1.5	  episodes	  per	  month)	  Highest	  number	  of	  episodes	  per	  day	  (RR	  =	  92%	  or	  49/53)	   1	  to	  6	  episodes	  per	  day	  (median	  1	  episode	  per	  day)∗	  	  Duration	  of	  episodes	  (RR	  =	  74%	  or	  39/53)	   10	  seconds	  to	  2	  hours	  (median	  5	  and	  ½	  minutes)°	  	  
Duration of the recovery time (RR	  =	  68%	  or	  36/53)	   Immediate	  recovery	  to	  2	  days	  (median	  7	  and	  ½	  hours)	  RR	  =	  response	  rate,	  ∗35% or 17/49 dogs had more than one episode per day,	  °31% or 12/39 dogs 418	  
had episodes lasting between 15 minutes and 2 hours	  	  419	   	  420	  421	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Legends to videos 422	  
Video 1. The dog in this video has a 1 year and 5 month history of recurrent episodes with a 423	  
recent increase in frequency to daily episodes.  The dog was examined by a veterinary neurologist 424	  
during a paroxysm of generalized dystonia and was found to have normal menace response in 425	  
both eyes and conscious postural reactions in all four limbs, muscle tone was increased in all four 426	  
limbs.  427	  
 428	  
Video 2. Paroxysmal involuntary movements in a Border terrier dog with a 3-year history of 429	  
episodes progressing in duration. The video displays the dog with generalized tremors, and 430	  
dystonia, more evident in the back legs. Panting and excessive salivation are also visible. When 431	  
the dog walks toward the box the leg is intentionally flexed but the movement exaggerated. 432	  
 433	  
